E

Evommune Inc.
D

EVMN

19.900
USD
-0.79
(-3.82%)
مغلق
حجم التداول
13,619
الربح لكل سهم
-2
العائد الربحي
-
P/E
-9
حجم السوق
716,765,603
المقالات
المزيد

العنوان: Evommune Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.